Toll-like receptor family polymorphisms are associated with primary renal diseases but not with renal outcomes following kidney transplantation

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Dessing, Mark C ^a,b   Kers, Jesper ^a   Damman, Jeffrey ^a   Leuvenink, Henri G D ^c   Van Goor, Harry ^c   Hillebrands, Jan Luuk ^c   Hepkema, Bouke G ^c   Snieder, Harold ^c   Van Den Born, Jacob ^c   De Borst, Martin H ^c   Bakker, Stephan J L ^c   Navis, Gerjan J ^c   Ploeg, Rutger J ^d   Florquin, Sandrine ^a,e   Seelen, Marc ^c   Leemans, Jaklien C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE RECEPTOR ANTAGONIST; GLUTAMINE; HISTIDINE; INTERLEUKIN 2 RECEPTOR ANTAGONIST; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHIONINE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID; PHENYLALANINE; SERINE; TACROLIMUS; THYMOCYTE ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; VALINE;

ACUTE GRAFT REJECTION; ADULT; AGE; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; END STAGE RENAL DISEASE; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GRAFT FAILURE; GRAFT RECIPIENT; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; GENETICS; GRAFT REJECTION; KIDNEY FAILURE, CHRONIC;

ADULT; CASE-CONTROL STUDIES; DELAYED GRAFT FUNCTION; FEMALE; GENE FREQUENCY; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS; TREATMENT OUTCOME;

EID: 84948702534     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139769     Document Type: Article

References (66)

1. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J. The role of Toll-like receptors in renal diseases. Nat Rev Nephrol. 2010; 6(4):224-35. doi: 10.1038/nrneph.2010.16 PMID: 20177402
2. Leemans JC, Kors L, Anders H-J, Florquin S. Pattern recognition receptors and the inflammasome in kidney disease. Nat Rev Nephrol. 2014; 10(7):398-414. doi: 10.1038/nrneph.2014.91 PMID: 24890433
3. Liew FY, Xu D, Brint EK, O'Neill LAJ. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol. 2005; 5(6):446-58. PMID: 15928677
4. Kawai T, Akira S. TLR signaling. Seminars in Immunology. 2007. p. 24-32. PMID: 17275323
5. Sivick KE, Mobley HLT. Waging war against uropathogenic Escherichia coli: Winning back the urinary tract. Infection and Immunity. 2010. p. 568-85. doi: 10.1128/IAI.01000-09 PMID: 19917708
6. Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A. 2009; 106(9):3390-5. doi: 10.1073/pnas.0810169106 PMID: 19218437
7. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int. 2005; 67(6):2454-61. PMID: 15882292
8. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, et al. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant. 2006; 20 (1):30-6. PMID: 16556150
9. Cervera C, Lozano F, Saval N, Gimferrer I, Ibañez A, Suárez B, et al. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation. 2007; 83(11):1493-500. PMID: 17565323
10. Fekete A, Viklicky O, Hubacek JA, Rusai K, Erdei G, Treszl A, et al. Association between heat shock protein 70s and toll-like receptor polymorphisms with long-term renal allograft survival. Transpl Int. 2006; 19(3):190-6. PMID: 16441767
11. Mutlubas F, Mir S, Berdeli A, Ozkayin N, Sozeri B. Association Between Toll-like Receptors 4 and 2 Gene Polymorphisms With Chronic Allograft Nephropathy in Turkish Children. Transpl Proc. 2009; 41 (5):1589-93.
12. Nogueira E, Ozaki KS, Macusso GD, Quarim RF, Cəmara NOS, Pacheco-Silva A. Incidence of Donor and Recipient Toll-Like Receptor-4 Polymorphisms in Kidney Transplantation. Transplant Proc. 2007; 39(2):412-4. PMID: 17362744
13. Krüger B, Banas MC, Walberer A, Böger CA, Farkas S, Hoffmann U, et al. A comprehensive genotypephenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond). 2010; 119(12):535-44.
14. Israni A, Leduc R, Holmes J, Jacobson PA, Lamba V, Guan W, et al. Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation. Transplantation. 2010; 90(12):1401-8. doi: 10.1097/TP.0b013e3182000085 PMID: 21085059
15. Srivastava P, Singh A, Kesarwani P, Jaiswal PK, Singh V, Mittal RD. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India. Clin Transpl. 2012; 26(4):581-8.
16. Eikmans M, de Canck I, van der Pol P, Baan CC, Haasnoot GW, Mallat MJK, et al. The Functional Polymorphism Ala258Ser in the Innate Receptor Gene Ficolin-2 in the Donor Predicts Improved Renal Transplant Outcome. Transplantation Journal. 2012. p. 478-85.
17. Kim TH, Jeong K-H, Kim SK, Lee SH, Ihm CG, Lee TW, et al. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients. Int J Immunogenet. 2013 Dec; 40(6):502-8. doi: 10.1111/iji.12069 PMID: 23758740
18. Krichen H, Gorgi Y, Dhaouadi T, Mecheri Y, Sfar I, Bardi R, et al. Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation. Transplant Proc. 2013; 45(10):3472-7. doi: 10. 1016/j.transproceed.2013.09.003 PMID: 24314935
19. Damman J, Daha MR, Leuvenink HG, Van Goor H, Hillebrands JL, Dijk MC Van, et al. Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys. Am J Transplant. 2012; 12(3):660-8. doi: 10.1111/j.1600-6143.2011.03880.x PMID: 22176838
20. Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MCRF, et al. CUBN as a novel locus for end-stage renal disease: Insights from renal transplantation. PLoS One. 2012; 7(5). doi: 10.1371/journal.pone.0036512 PMID: 22574174
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M a R, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81 (3):559-75. PMID: 17701901
22. Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT. Basic statistical analysis in genetic case-control studies. Nat Protoc. 2011; 6(2):121-33. doi: 10.1038/nprot.2010.182 PMID: 21293453
23. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006 Feb; 38(2):209-13. PMID: 16415888
24. Randhawa AK, Shey MS, Keyser A, Peixoto B, Wells RD, de Kock M, et al. Association of human TLR1 and TLR6 deficiency with altered immune responses to bcg vaccination in south african infants. PLoS Pathog. 2011; 7(8). doi: 10.1371/journal.ppat.1002174 PMID: 21852947
25. Shey MS, Randhawa AK, Bowmaker M, Smith E, Scriba TJ, de Kock M, et al. Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide-And mycobacteria-induced interleukin-6 secretion. Genes Immun. 2010; 11(7):561-72. doi: 10.1038/gene.2010.14 PMID: 20445564
26. Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI. The polymorphism P315L of human tolllike receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol. 2007; 178 (10):6387-94. PMID: 17475868
27. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, et al. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol. 2007; 178(12):7520-4. PMID: 17548585
28. Xiong Y, Song C, Snyder GA, Sundberg EJ, Medvedev AE. R753Q polymorphism inhibits toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88 J Biol Chem. 2012; 287(45):38327-37. doi: 10.1074/jbc.M112. 375493 PMID: 22992740
29. Schröder NWJ, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol. 2005; 175(4):2534-40. PMID: 16081826
30. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun. 2000; 68(11):6398-401. PMID: 11035751
31. Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I, et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem. 2007; 282 (24):17696-705. PMID: 17434873
32. Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JLF, Varela J, et al. A role for toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem. 2010; 285(30):23208-23. doi: 10.1074/jbc.M109.047464 PMID: 20472559
33. Sironi M, Biasin M, Cagliani R, Forni D, De Luca M, Saulle I, et al. A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J Immunol. American Association of Immunologists; 2012 Jan 15; 188(2):818-23.
34. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000; 25(2):187-91. PMID: 10835634
35. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002; 347(3):185-92. PMID: 12124407
36. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med. 2003; 198(10):1563-72. PMID: 14623910
37. Hawn TR, Wu H, Grossman JM, Hahn BH, Tsao BP, Aderem A. A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2005; 102(30):10593-7. PMID: 16027372
38. West TE, Chantratita N, Chierakul W, Limmathurotsakul D, Wuthiekanun V, Myers ND, et al. Impaired TLR5 functionality is associated with survival in melioidosis. J Immunol. 2013; 190(7):3373-9. doi: 10. 4049/jimmunol.1202974 PMID: 23447684
39. Klimosch SN, Försti A, Eckert J, Knezevic J, Bevier M, von Schönfels W, et al. Functional TLR5 genetic variants affect human colorectal cancer survival. Cancer Res. 2013; 73(24):7232-42. doi: 10.1158/0008-5472.CAN-13-1746 PMID: 24154872
40. Sheridan J, Mack DR, Amre DK, Israel DM, Cherkasov A, Li H, et al. A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn's disease and influences responses to bacterial flagellin. PLoS One. Public Library of Science; 2013 Jan 11; 8(4):e61326. doi: 10.1371/journal.pone.0061326 PMID: 23593463
41. Dhiman N, Ovsyannikova IG, Vierkant RA, Ryan JE, Shane Pankratz V, Jacobson RM, et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results. Vaccine. 2008; 26(14):1731-6. doi: 10.1016/j. vaccine.2008.01.017 PMID: 18325643
42. Oh D-Y, Baumann K, Hamouda O, Eckert JK, Neumann K, Kücherer C, et al. A frequent functional tolllike receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS. 2009; 23(3):297-307. doi: 10.1097/QAD.0b013e32831fb540 PMID: 19114863
43. Askar E, Ramadori G, Mihm S. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection. J Med Virol. 2010 Nov; 82(11):1859-68. doi: 10.1002/jmv.21893 PMID: 20872712
44. Wang C-H, Eng H-L, Lin K-H, Liu H-C, Chang C-H, Lin T-M. Functional Polymorphisms of TLR8 Are Associated With Hepatitis C Virus Infection. Immunology. 2013
45. Oh D-Y, Taube S, Hamouda O, Kücherer C, Poggensee G, Jessen H, et al. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis. 2008; 198(5):701-9. doi: 10.1086/590431 PMID: 18605904
46. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJD, Kirschning CJ, et al. Renal-Associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005 Oct 1; 115(10):2894-903. PMID: 16167081
47. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007; 117(10):2847-59. PMID: 17853945
48. Farrar CA, Keogh B, McCormackW, O'Shaughnessy A, Parker A, Reilly M, et al. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. The FASEB Journal. 2012. p. 799-807. doi: 10.1096/fj.11-195396 PMID: 22042224
49. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol. 2007; 178(10):6252-8. PMID: 17475853
50. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, Luirink IK, et al. TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol. 2010; 21(8):1299-308. doi: 10.1681/ASN.2009070722 PMID: 20595685
51. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der Poll T, Florquin S, et al. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One. 2008; 3(10). doi: 10.1371/journal.pone.0003596 PMID: 18974879
52. Leemans JC, Butter LM, Pulskens WPC, Teske GJD, Claessen N, van der Poll T, et al. The role of tolllike receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One. 2009; 4(5). doi: 10.1371/journal.pone.0005704 PMID: 19479087
53. Noris M, Cassis P, Azzollini N, Cavinato R, Cugini D, Casiraghi F, et al. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J Immunol. 2009; 183(7):4249-60 doi: 10.4049/jimmunol.0803549 PMID: 19734209
54. Skuginna V, Lech M, Allam R, Ryu M, Clauss S, Susanti HE, et al. Toll-like receptor signaling and sigirr in renal fibrosis upon unilateral ureteral obstruction. PLoS One. 2011; 6(4). doi: 10.1371/journal.pone. 0019204 PMID: 21544241
55. Lech M, Avila-Ferrufino A, Allam R, Segerer S, Khandoga A, Krombach F, et al. Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J Immunol. 2009; 183(6):4109-18. doi: 10.4049/jimmunol.0900118 PMID: 19692646
56. Lee JS, Park H-K, Suh J-S, Hahn W-H, Kang SW, Park HJ, et al. Toll-like receptor 1 gene polymorphisms in childhood IgA nephropathy: a case-control study in the Korean population. Int J Immunogenet. 2011; 38(2):133-8. doi: 10.1111/j.1744-313X.2010.00978.x PMID: 21108742
57. Cheng C-H, Lee Y-S, Chang C-J, Lin T-Y. Genetic polymorphisms in Toll-like receptors among pediatric patients with renal parenchymal infections of different clinical severities. PLoS One. 2013; 8(3): e58687. doi: 10.1371/journal.pone.0058687 PMID: 23484049
58. Mutlubas F, Mir S, Berdeli A, Ozkayin N, Sozeri B. Association Between Toll-like Receptors 4 and 2 Gene Polymorphisms With Chronic Allograft Nephropathy in Turkish Children. Transplant Proc. 2009; 41(5):1589-93. doi: 10.1016/j.transproceed.2009.02.079 PMID: 19545686
59. Soylu A, Kizildag S, Kavukçu S, Cingöz S, Türkmen M, Demir BK, et al. TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch Schonlein purpura with and without renal involvement. Rheumatol Int. 2010; 30(5):667-70. doi: 10.1007/s00296-009-1052-y PMID: 19597734
60. Akil I, Ozkinay F, Onay H, Canda E, Gumuser G, Kavukcu S. Assessment of toll-like receptor-4 gene polymorphism on pyelonephritis and renal scar. Int J Immunogenet. 2012; 39(4):303-7. doi: 10.1111/j. 1744-313X.2012.01090.x PMID: 22308961
61. Karoly E, Fekete A, Banki NF, Szebeni B, Vannay A, Szabo AJ, et al. Heat shock protein 72 (HSPA1B) gene polymorphism and toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr Res. 2007; 61(3):371-4. PMID: 17314700
62. Bayram MT, Soylu A, Ate H, Kizildag S, Kavukçu S. TLR-4 polymorphisms and leukocyte TLR-4 expression in febrile UTI and renal scarring. Pediatr Nephrol. 2013; 28(9):1827-35. doi: 10.1007/s00467-013-2478-8 PMID: 23612767
63. Fekete A, Viklický O, Hubácek JA, Rusai K, Erdei G, Treszl A, et al. Association between heat shock protein 70s and toll-like receptor polymorphisms with long-term renal allograft survival. Transpl Int. 2006; 19(3):190-6. PMID: 16441767
64. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, et al. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-And TRIF-dependent signaling. Dis Model Mech. 2010 Jan 1; 3(1-2):92-103. doi: 10.1242/dmm.003533 PMID: 20038715
65. Wu J-F, Chen C-H, Ni Y-H, Lin Y-T, Chen H-L, Hsu H-Y, et al. Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan. J Infect Dis. 2012; 206(5):662-8. doi: 10.1093/infdis/jis420 PMID: 22740716
66. Chen L, Wang T, Zhou P, Ma L, Yin D, Shen J, et al. TLR engagement prevents transplantation tolerance. Am J Transplant. 2006; 6(10):2282-91. PMID: 16970798